Workflow
科拓生物(300858) - 300858科拓生物业绩说明会20250508
300858Scitop Bio(300858)2025-05-08 10:53

Group 1: Industry Overview - The domestic probiotics raw material market is dominated by multinational companies like DuPont and Chr. Hansen, which together hold over 80% market share, indicating a need for increased market share of domestic strains [2] - The probiotics industry is experiencing robust growth due to rising consumer health awareness and the rapid development of functional food markets [3] Group 2: Company Performance - In 2024, the company achieved operating revenue of 302.79 million CNY, a year-on-year increase of 1.19%, with the edible probiotics segment growing by 20.85% [4] - The net profit attributable to the parent company was 94.36 million CNY, reflecting a year-on-year growth of 0.94% [4] Group 3: Future Growth Drivers - The edible probiotics segment is the largest revenue contributor and has the strongest profitability, representing a key growth point for the company [3] - The company plans to increase R&D investment, enhance product development and market coverage, and strengthen brand influence to expand market share [3]